Atrás
Rango del Día
$2.13
$2.60
Rango de 52 Semanas
$0.86
$2.80
Volumen
11,639,138
Promedio 50D / 200D
$2.01
/
$1.45
Cierre Anterior
$2.07
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -2.9 | 0.4 |
| P/B | 1.9 | 2.9 |
| ROE % | -53.4 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.3 | 0.2 |
Puntos Clave
Debt/Equity of 0.26 — conservative balance sheet
Negative free cash flow of -149.63M
PEG of 0.05 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)-100.00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-53.42%
ROIC-42.22%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.26
Current Ratio7.93
Interest Coverage-192.50
Valoración
P/E Ratio
-2.87
P/B Ratio1.87
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100.00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -190.89M |
| ROE | -53.42% | ROA | -45.90% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -149.63M |
| ROIC | -42.22% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.26 | Current Ratio | 7.93 |
| Interest Coverage | -192.50 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -2.87 | P/B Ratio | 1.87 |
| P/S Ratio | N/A | PEG Ratio | 0.05 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 548.34M | Enterprise Value | 571.70M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 22,000.0 | 95,000.0 | 156,000.0 | 114.09M |
| Net Income | -190.89M | -257.59M | -327.27M | -340.41M | -182.05M |
| EPS (Diluted) | -0.87 | -1.32 | -2.09 | -2.38 | -1.34 |
| Gross Profit | -12.36M | 22,000.0 | 95,000.0 | -14.14M | 114.09M |
| Operating Income | -206.93M | -273.20M | -327.74M | -335.54M | -180.19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 415.91M | 548.71M | 642.84M | 821.58M | 1.05B |
| Total Liabilities | 123.36M | 126.53M | 130.60M | 154.70M | 125.63M |
| Shareholders' Equity | 292.54M | 422.18M | 512.23M | 666.88M | 925.20M |
| Total Debt | 75.05M | 90.76M | 95.12M | 101.12M | 73.13M |
| Cash & Equivalents | 51.69M | 75.22M | 83.16M | 61.90M | 173.31M |
| Current Assets | 257.75M | 303.39M | 459.12M | 528.82M | 471.32M |
| Current Liabilities | 32.51M | 35.52M | 37.08M | 53.73M | 47.91M |